Production (Stage)
Kronos Bio, Inc.
KRON
$0.872
$0.00210.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -26.03% | -0.70% | 158.45% | 44.21% | 106.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.03% | -0.70% | 158.45% | 44.21% | 106.39% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -26.03% | -0.70% | 158.45% | 44.21% | 106.39% |
| SG&A Expenses | -27.00% | -44.14% | -36.43% | -35.85% | -22.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -62.09% | -52.24% | -47.94% | -35.30% | -26.88% |
| Operating Income | 66.82% | 56.84% | 53.54% | 40.36% | 32.59% |
| Income Before Tax | 72.08% | -1.95% | 55.03% | 45.53% | -14.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 72.08% | -1.95% | 55.03% | 45.53% | -14.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.08% | -1.95% | 55.03% | 45.53% | -14.18% |
| EBIT | 66.82% | 56.84% | 53.54% | 40.36% | 32.59% |
| EBITDA | 67.15% | 57.64% | 54.06% | 40.62% | 32.91% |
| EPS Basic | 72.68% | 1.54% | 56.65% | 47.97% | -9.63% |
| Normalized Basic EPS | 69.83% | 59.82% | 56.64% | 44.37% | 37.18% |
| EPS Diluted | 72.68% | 1.54% | 56.65% | 47.97% | -9.63% |
| Normalized Diluted EPS | 69.83% | 59.82% | 56.64% | 44.37% | 37.18% |
| Average Basic Shares Outstanding | 2.16% | 3.56% | 3.72% | 4.71% | 4.15% |
| Average Diluted Shares Outstanding | 2.16% | 3.56% | 3.72% | 4.71% | 4.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |